Michel Devleeschouwer

1.5k total citations
53 papers, 1.2k citations indexed

About

Michel Devleeschouwer is a scholar working on Molecular Biology, Molecular Medicine and Pharmaceutical Science. According to data from OpenAlex, Michel Devleeschouwer has authored 53 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 11 papers in Molecular Medicine and 8 papers in Pharmaceutical Science. Recurrent topics in Michel Devleeschouwer's work include Bacterial biofilms and quorum sensing (10 papers), Antibiotic Resistance in Bacteria (10 papers) and Cystic Fibrosis Research Advances (6 papers). Michel Devleeschouwer is often cited by papers focused on Bacterial biofilms and quorum sensing (10 papers), Antibiotic Resistance in Bacteria (10 papers) and Cystic Fibrosis Research Advances (6 papers). Michel Devleeschouwer collaborates with scholars based in Belgium, France and Democratic Republic of the Congo. Michel Devleeschouwer's co-authors include Rasmané Semdé, André Jules Moes, Karim Amighi, Marie Tré‐Hardy, Pierre Duez, André Barel, Irene Manou, Hamidou Traore, Francis Vanderbist and F. Portaels and has published in prestigious journals such as Applied and Environmental Microbiology, Journal of Clinical Microbiology and Applied Microbiology and Biotechnology.

In The Last Decade

Michel Devleeschouwer

52 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michel Devleeschouwer Belgium 19 353 260 227 192 169 53 1.2k
Inés Albesa Argentina 20 592 1.7× 166 0.6× 136 0.6× 183 1.0× 114 0.7× 76 1.5k
Rossella Grande Italy 32 906 2.6× 348 1.3× 262 1.2× 215 1.1× 229 1.4× 70 2.6k
Ronette Gehring United States 29 282 0.8× 444 1.7× 185 0.8× 93 0.5× 142 0.8× 151 2.7k
G.W. Hanlon United Kingdom 18 533 1.5× 152 0.6× 72 0.3× 100 0.5× 91 0.5× 55 1.3k
Carl E. Catrenich United States 17 483 1.4× 337 1.3× 154 0.7× 134 0.7× 59 0.3× 21 1.6k
Misagh Alipour Canada 19 699 2.0× 342 1.3× 189 0.8× 96 0.5× 118 0.7× 26 1.6k
Veeranoot Nissapatorn Thailand 27 568 1.6× 268 1.0× 246 1.1× 363 1.9× 221 1.3× 140 2.2k
Praveen Rishi India 26 833 2.4× 546 2.1× 165 0.7× 244 1.3× 133 0.8× 116 2.1k
Stuart Shapiro Switzerland 28 977 2.8× 305 1.2× 209 0.9× 371 1.9× 274 1.6× 71 2.8k
Pio Maria Furneri Italy 25 526 1.5× 467 1.8× 148 0.7× 129 0.7× 213 1.3× 91 1.7k

Countries citing papers authored by Michel Devleeschouwer

Since Specialization
Citations

This map shows the geographic impact of Michel Devleeschouwer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michel Devleeschouwer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michel Devleeschouwer more than expected).

Fields of papers citing papers by Michel Devleeschouwer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michel Devleeschouwer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michel Devleeschouwer. The network helps show where Michel Devleeschouwer may publish in the future.

Co-authorship network of co-authors of Michel Devleeschouwer

This figure shows the co-authorship network connecting the top 25 collaborators of Michel Devleeschouwer. A scholar is included among the top collaborators of Michel Devleeschouwer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michel Devleeschouwer. Michel Devleeschouwer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nagant, Carole, Marie Tré‐Hardy, Michel Devleeschouwer, & Jean‐Paul Dehaye. (2010). Study of the initial phase of biofilm formation using a biofomic approach. Journal of Microbiological Methods. 82(3). 243–248. 14 indexed citations
2.
Nagant, Carole, et al.. (2010). Interaction between tobramycin and CSA-13 on clinical isolates of Pseudomonas aeruginosa in a model of young and mature biofilms. Applied Microbiology and Biotechnology. 88(1). 251–263. 22 indexed citations
3.
Tré‐Hardy, Marie, et al.. (2009). Evaluation of long-term co-administration of tobramycin and clarithromycin in a mature biofilm model of cystic fibrosis clinical isolates of Pseudomonas aeruginosa. International Journal of Antimicrobial Agents. 34(4). 370–374. 19 indexed citations
4.
Tré‐Hardy, Marie, et al.. (2008). Effect of antibiotic co-administration on young and mature biofilms of cystic fibrosis clinical isolates: the importance of the biofilm model. International Journal of Antimicrobial Agents. 33(1). 40–45. 42 indexed citations
5.
Tré‐Hardy, Marie, Francis Vanderbist, Hamidou Traore, & Michel Devleeschouwer. (2008). In vitro activity of antibiotic combinations against Pseudomonas aeruginosa biofilm and planktonic cultures. International Journal of Antimicrobial Agents. 31(4). 329–336. 79 indexed citations
6.
Devleeschouwer, Michel, et al.. (2007). Direct and indirect antimicrobial effects and antioxidant activity of Cordia gilletii De Wild (Boraginaceae). Journal of Ethnopharmacology. 112(3). 476–481. 64 indexed citations
7.
Pochet, Stéphanie, Marie Tré‐Hardy, Mikel Garcia‐Marcos, et al.. (2006). Modulation by LL-37 of the Responses of Salivary Glands to Purinergic Agonists. Molecular Pharmacology. 69(6). 2037–2046. 25 indexed citations
8.
Semdé, Rasmané, André Jules Moes, Michel Devleeschouwer, & Karim Amighi. (2002). In vitro evaluation of epichlorohydrin cross-linked pectins as colon-specific drug delivery carriers. Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles). 12(5). 293–298. 5 indexed citations
9.
Vooren, J P Van, et al.. (2000). Spontaneous apoptosis and highly active antiretroviral therapy (HAART). Biomedicine & Pharmacotherapy. 54(1). 16–20. 9 indexed citations
10.
Semdé, Rasmané, Karim Amighi, Michel Devleeschouwer, & André Jules Moes. (2000). Studies of pectin HM/Eudragit® RL/Eudragit® NE film-coating formulations intended for colonic drug delivery. International Journal of Pharmaceutics. 197(1-2). 181–192. 80 indexed citations
11.
Semdé, Rasmané, Karim Amighi, Michel Devleeschouwer, & André Jules Moes. (2000). Effect of pectinolytic enzymes on the theophylline release from pellets coated with water insoluble polymers containing pectin HM or calcium pectinate. International Journal of Pharmaceutics. 197(1-2). 169–179. 67 indexed citations
12.
Semdé, Rasmané, Karim Amighi, Michel Devleeschouwer, & André Jules Moes. (1999). In vitro evaluation of pectin HM/ethylcellulose compression-coated formulations intended for colonic drug delivery. Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles). 9(6). 561–565. 5 indexed citations
13.
Devleeschouwer, Michel, et al.. (1994). Influence of protamine on the in vitro sensitivity of Pseudomonas aeruginosa to antibiotics. Pharmaceutica Acta Helvetiae. 68(3). 161–167.
14.
Devleeschouwer, Michel, et al.. (1993). Bactericidal activity of disinfectants on listeria. Journal of Applied Bacteriology. 74(4). 480–483. 29 indexed citations
15.
Devleeschouwer, Michel, et al.. (1993). Relationship between slime production, antibiotic sensitivity and the phagetype of coagulase–negative staphylococci. Journal of Clinical Pharmacy and Therapeutics. 18(4). 271–274. 14 indexed citations
16.
Devleeschouwer, Michel, et al.. (1989). DISINFECTANTS PREPARED IN A HOSPITAL PHARMACY—ASSESSMENT OF THEIR MICROBIOLOGICAL PURITY AND ANTIMICROBIAL EFFECTIVENESS. Journal of Clinical Pharmacy and Therapeutics. 14(6). 457–464. 1 indexed citations
17.
Devleeschouwer, Michel, Sven De Mæyer, C. Godard, et al.. (1988). Marked increase ofPseudomonas aeruginosa serotype 012 in Belgium since 1982. European Journal of Clinical Microbiology & Infectious Diseases. 7(2). 265–269. 18 indexed citations
18.
Vanhaelen, Maurice, et al.. (1986). Antibacterial activity of three indole alkaloids extracted from Hannoa klaineana roots. Fitoterapia. 57(4). 291–293. 2 indexed citations
19.
Devleeschouwer, Michel, et al.. (1985). Electrode bactérienne en vue de l'utilisation analytique du métabolisme oxydatif du L-tryptophane de pseudomonas fluorescens. Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles). 40(6). 357–365. 1 indexed citations
20.
Kauffmann, Jean‐Michel, et al.. (1984). Nouveau modèle d'électrode enzymatique pour la détermination du glucose : applications aux milieux biologiques. Analusis. 12(3). 141–147. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Inés Albesa Breakdown of academic impact, for papers by Rossella Grande Breakdown of academic impact, for papers by Ronette Gehring Breakdown of academic impact, for papers by G.W. Hanlon Breakdown of academic impact, for papers by Carl E. Catrenich Breakdown of academic impact, for papers by Misagh Alipour Breakdown of academic impact, for papers by Veeranoot Nissapatorn Breakdown of academic impact, for papers by Praveen Rishi Breakdown of academic impact, for papers by Stuart Shapiro Breakdown of academic impact, for papers by Pio Maria Furneri
Rankless by CCL
2026